Author:
Lounis Mohamed,Rais Mohammed Amir,Bencherit Djihad,Aouissi Hani Amir,Oudjedi Adda,Klugarová Jitka,Pokorná Andrea,Klugar Miloslav,Riad Abanoub
Abstract
Healthcare workers were prioritized in vaccination campaigns globally because they are exposed to the highest risk of contamination by SARS-CoV-2. This study evaluated the self-reported post-vaccination side effects of inactivated (BBIBP-CorV and CoronaVac) and adenoviral vector-based (AZD1222, Gam-COVID-Vac and Ad26.COV2.S) vaccines among Algerian healthcare workers using a validated questionnaire. The final analysis included 721 healthcare workers, with a predominance of females (59.1%) and younger individuals 20–30 years old (39.4%). Less than half (49.1%) of the respondents reported at least one local side effect, while 53.8% reported at least one systemic side effect. These side effects were more prevalent among viral vector vaccinees than inactivated virus vaccinees. The most common local side effects were injection site pain (39%) and arm pain (25.4%), while fatigue (34.4%), fever (28.4%), headache (24.8%) and myalgia (22.7%) were the most prevalent systemic side effects. The side effects appeared earlier among inactivated virus vaccines recipients and generally lasted for 2 to 3 days for the two vaccinated groups. The risk factors associated with a higher prevalence of side effects included female gender, allergic individuals, individuals with regular medication, those who contracted the COVID-19 disease and those who received two doses for both inactivated and viral-based vaccines groups. Despite the higher prevalence of post-vaccination side effects among adenoviral vector vaccines recipients, both vaccines groups were equally effective in preventing symptomatic infections, and no life-threatening side effects were reported in either vaccine group.
Subject
Public Health, Environmental and Occupational Health
Reference58 articles.
1. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data
2. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review;Nussbaumer-Streit;Cochrane Database Syst Rev.,2020
3. Covid-19: Unvaccinated face 11 times risk of death from delta variant, CDC data show;Dyer;BMJ.,2021
4. Features, Evaluation, and Treatment of Coronavirus (COVID-19) CascellaM RajnikM AleemA DulebohnSC Napoli RDi 32150360Treasure Island (FL)StatPearls PublishingStatPearls2021
5. Four months into the COVID-19 pandemic, Sweden's prized herd immunity is nowhere in sight;Orlowski;J R Soc Med.,2020
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献